SYNCOM FORMULATIONS Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SYNCOM FORMULATIONS Quarterly Results    (SFRM)

Here are the latest quarterly results of SYNCOM FORMULATIONS. For more details, see the SYNCOM FORMULATIONS financial fact sheet and SYNCOM FORMULATIONS share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

SYNCOM FORMULATIONS Quarterly Results

No. of Mths
Qtr. Ending
3
Sep-19
*
3
Dec-19
*
3
Mar-20
*
3
Jun-20
*
3
Sep-20
*
3
Dec-20
*
3
Mar-21
*
3
Jun-21
*
8-Qtr Chart
Click to enlarge
Net Sales Rs m563523430292659842655513 
Other income Rs m101316913123713 
Turnover Rs m573536446301672854693526 
Expenses Rs m513480395251536711571443 
Gross profit Rs m494336411231308470 
Depreciation Rs m1010101010101110 
Interest Rs m11300022 
Profit before tax Rs m4945384012513211072 
Tax Rs m61031033324018 
Profit after tax Rs m43353530921006954 
Gross profit margin %8.88.38.314.118.615.512.913.7 
Effective tax rate %11.922.28.725.626.324.236.625.1 
Net profit margin %7.66.78.110.114.011.910.610.5 
Diluted EPS Rs 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.1  
Diluted EPS (TTM) Rs 0.2 0.2 0.2 0.2 0.2 0.3 0.4 0.4  
 Subscriber Feature                  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster

More Pharmaceuticals Company Quarterly Results:   CHOKSI LAB.  BAL PHARMA  TRIMURTHI DRUGS  EVEREST ORGANICS  BACIL PHARMA  

Compare SYNCOM FORMULATIONS With:   CHOKSI LAB.  BAL PHARMA  TRIMURTHI DRUGS  EVEREST ORGANICS  BACIL PHARMA  



Today's Market

Sensex Ends 456 Points Lower; Midcap and Smallcap Stocks Witness Heavy Selling(Closing)

After opening the day on a flat note, Indian share markets witnessed heavy selling in the afternoon session and ended lower.

Views on news

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

Block Deal Disappoints Max Healthcare Shareholders. Stock Falls 6% (Views On News)

Sep 30, 2021

The divestment of 6.6% stake by the promoter is considered to be one of the largest block deals of the market.

5 Indian Pharma Companies Riding the Vaccination Wave (Views On News)

Sep 3, 2021

These companies are likely to benefit the most from Covid-19 vaccines.

Apollo Hospitals' Shares Rally Over 5%, Hit Record-High on Strong Results (Views On News)

Aug 16, 2021

The company reported a 73% YoY increase in revenue driven by an uptick in the hospital and pharmacy business.

J B Chemicals & Pharma's Decent Performance Puts Stock in Focus (Views On News)

Aug 13, 2021

The company seeks to expand the market for prescription lozenges with new launches this year.

More Views on News

Most Popular

Is it Time to Switch from Tata Power to NTPC? (Profit Hunter)

Oct 11, 2021

Given the huge run up in Tata Power, does it make sense to switch to NTPC?

This Proxy EV Stock Just got a Power Crisis Boost (Profit Hunter)

Oct 8, 2021

After months of research, I've come across few stocks that excite me far more than the mainstream electric vehicle companies.

Rs 1 Lakh Invested in These Cryptos at the Start of 2021 Became Rs... (Views On News)

Oct 8, 2021

These cryptos would have multiplied investors' wealth by as much as 10,000% in just nine months.

5 Exciting 'Unlisted' Companies and How to Play Them (Views On News)

Oct 7, 2021

Here's how you can invest in some of the most exciting start-ups of the decade.

Modi's Big Move Could Boost these 5 Defence Stocks (Views On News)

Oct 11, 2021

To corporatise the defence sector, the Ministry of Defence (MoD) has dissolved the 250-year-old Ordnance Factory Board (OFB).

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SYNCOM FORMULATIONS SHARE PRICE


Oct 20, 2021 (Close)

TRACK SYNCOM FORMULATIONS

  • Track your investment in SYNCOM FORMULATIONS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SYNCOM FORMULATIONS

SYNCOM FORMULATIONS 5-YR ANALYSIS

COMPARE SYNCOM FORMULATIONS WITH

MARKET STATS